| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Expression of DeltaNp73 is a molecular marker for adverse outcome in neuroblastoma patients.
|
Cell Death Differ
|
2002
|
2.14
|
|
2
|
Quality assessment of genetic markers used for therapy stratification.
|
J Clin Oncol
|
2003
|
1.92
|
|
3
|
Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study).
|
Br J Cancer
|
2011
|
1.09
|
|
4
|
Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project.
|
Br J Cancer
|
2012
|
1.09
|
|
5
|
Expression of B-myb in neuroblastoma tumors is a poor prognostic factor independent from MYCN amplification.
|
Cancer Res
|
1999
|
1.03
|
|
6
|
Expression of MAGE-1, MAGE-3 and MART-1 genes in neuroblastoma.
|
Int J Cancer
|
1996
|
0.97
|
|
7
|
DNA-functionalized solid state nanopore for biosensing.
|
Nanotechnology
|
2010
|
0.94
|
|
8
|
Erythroid differentiation and modulation of c-myc expression induced by antineoplastic drugs in the human leukemic cell line K562.
|
Cancer Res
|
1987
|
0.90
|
|
9
|
Localized unresectable neuroblastoma: results of treatment based on clinical prognostic factors.
|
Ann Oncol
|
2002
|
0.88
|
|
10
|
Proliferation-associated Brn-3b transcription factor can activate cyclin D1 expression in neuroblastoma and breast cancer cells.
|
Oncogene
|
2007
|
0.88
|
|
11
|
Somatostatin receptor type 2 gene expression in neuroblastoma, measured by competitive RT-PCR, is related to patient survival and to somatostatin receptor imaging by indium -111-pentetreotide.
|
Med Pediatr Oncol
|
2001
|
0.87
|
|
12
|
Different p73 splicing variants are expressed in distinct tumour areas of a multifocal neuroblastoma.
|
Cell Death Differ
|
1999
|
0.86
|
|
13
|
Genomic aberrations in normal appearing mucosa fields distal from oral potentially malignant lesions.
|
Cell Oncol (Dordr)
|
2011
|
0.86
|
|
14
|
p27Kip1 accumulation is associated with retinoic-induced neuroblastoma differentiation: evidence of a decreased proteasome-dependent degradation.
|
Oncogene
|
2000
|
0.86
|
|
15
|
Quantitative determination of sst2 gene expression in neuroblastoma tumor predicts patient outcome.
|
J Clin Endocrinol Metab
|
2000
|
0.86
|
|
16
|
A new human highly tumorigenic neuroblastoma cell line with undetectable expression of N-myc.
|
Pediatr Res
|
1990
|
0.86
|
|
17
|
Biological and clinical role of p73 in neuroblastoma.
|
Cancer Lett
|
2003
|
0.84
|
|
18
|
Role of methylation in the control of DeltaNp73 expression in neuroblastoma.
|
Cell Death Differ
|
2002
|
0.84
|
|
19
|
Structural and functional analysis of cyclin-dependent kinase inhibitor genes (CDKN2A, CDKN2B, and CDKN2C) in neuroblastoma.
|
Pediatr Res
|
1998
|
0.82
|
|
20
|
Isolation and functional assessment of common, polymorphic variants of the B-MYB proto-oncogene associated with a reduced cancer risk.
|
Oncogene
|
2007
|
0.82
|
|
21
|
Electrical characterization of DNA-functionalized solid state nanopores for bio-sensing.
|
J Phys Condens Matter
|
2010
|
0.82
|
|
22
|
Evidence of loss of N-myc amplification during the establishment of a human neuroblastoma cell line.
|
Int J Cancer
|
1990
|
0.81
|
|
23
|
Subcellular details of early events of differentiation induced by retinoic acid in human neuroblastoma cells detected by atomic force microscope.
|
Exp Cell Res
|
1995
|
0.81
|
|
24
|
Cytogenetic and molecular study of two human neuroblastoma cell lines.
|
Cancer Genet Cytogenet
|
1988
|
0.81
|
|
25
|
PHOX2A and PHOX2B genes are highly co-expressed in human neuroblastoma.
|
Int J Oncol
|
2008
|
0.81
|
|
26
|
Interstitial and large chromosome 1p deletion occurs in localized and disseminated neuroblastomas and predicts an unfavourable outcome.
|
Cancer Lett
|
1998
|
0.80
|
|
27
|
Lack of p73 expression in mature B-ALL and identification of three new splicing variants restricted to pre B and C-ALL indicate a role of p73 in B cell ALL differentiation.
|
Leukemia
|
2000
|
0.80
|
|
28
|
Detection of DNA polymorphisms and point mutations of high-affinity nerve growth factor receptor (TrkA) in human neuroblastoma.
|
Int J Oncol
|
1999
|
0.80
|
|
29
|
Reduced expression of transforming growth factor-beta receptor type III in high stage neuroblastomas.
|
Br J Cancer
|
2000
|
0.79
|
|
30
|
Impact of MDM2 SNP309 genotype on progression and survival of stage 4 neuroblastoma.
|
Eur J Cancer
|
2008
|
0.79
|
|
31
|
Numerical and structural aberrations in advanced neuroblastoma tumours by CGH analysis; survival correlates with chromosome 17 status.
|
Br J Cancer
|
2000
|
0.79
|
|
32
|
Age-dependent prognostic significance of N-myc amplification in neuroblastoma. The Italian experience.
|
Cancer Genet Cytogenet
|
1991
|
0.79
|
|
33
|
Real-time quantitative PCR for the measurement of MYCN amplification in human neuroblastoma with the TaqMan detection system.
|
Clin Chem
|
1999
|
0.79
|
|
34
|
Molecular alterations in a case of bilateral adrenal neuroblastoma.
|
Med Pediatr Oncol
|
2001
|
0.79
|
|
35
|
Immunological evaluation of 22 patients with acute lymphoblastic leukemia off-therapy. A longitudinal follow-up.
|
Helv Paediatr Acta
|
1981
|
0.78
|
|
36
|
Neurite outgrowth and cell cycle kinetic changes induced by cis-diamminedichloroplatinum II and retinoic acid in a human neuroblastoma cell line.
|
Cancer Lett
|
1990
|
0.78
|
|
37
|
Letter: Immunological side-effects of anticonvulsants.
|
Lancet
|
1976
|
0.78
|
|
38
|
Neuroblastoma in two siblings supports the role of 1p36 deletion in tumor development.
|
Cancer Genet Cytogenet
|
1999
|
0.78
|
|
39
|
Expression of multiple drug resistance gene, MDR1, and N-myc oncogene in an Italian population of human neuroblastoma patients.
|
Anticancer Res
|
1990
|
0.78
|
|
40
|
Peculiar allelotype associated with susceptibility to neuroblastoma.
|
Genes Chromosomes Cancer
|
1996
|
0.78
|
|
41
|
Coordinate change of c-myc, transferrin receptor and H3 gene expression precedes induction of haemoglobin-producing cells of the leukaemia K562 cell line treated with cis-diamminedichloroplatinum (II).
|
Anticancer Res
|
1991
|
0.78
|
|
42
|
N-myc oncogene amplification in a patient with IV-S neuroblastoma.
|
Am J Pediatr Hematol Oncol
|
1987
|
0.78
|
|
43
|
N-myc gene amplification/expression in localized stroma-rich neuroblastoma (ganglioneuroblastoma).
|
Hum Pathol
|
1993
|
0.78
|
|
44
|
Genome and transcriptome analysis of neuroblastoma advanced diagnosis from innovative therapies.
|
Curr Pharm Des
|
2009
|
0.77
|
|
45
|
Morphological change and cellular differentiation induced by cisplatin in human neuroblastoma cell lines.
|
Cancer Chemother Pharmacol
|
1989
|
0.77
|
|
46
|
Stage-independent expression and genetic analysis of tp73 in neuroblastoma.
|
Int J Cancer
|
1999
|
0.77
|
|
47
|
Expression of histone H3 cell cycle-related gene, vimentin and MYC genes in pediatric brain tumors. A preliminary analysis showing the different malignant cell growth potential.
|
Brain Res Mol Brain Res
|
1992
|
0.77
|
|
48
|
Identification of an AP-1-like sequence in the promoter region of calcyclin, a S-100-like gene. Enhancement of binding during retinoic acid-induced neuroblastoma cell differentiation.
|
Neurosci Lett
|
1994
|
0.76
|
|
49
|
Refined chromosomal localization of the putative tumor suppressor gene TP73.
|
Cytogenet Cell Genet
|
1998
|
0.76
|
|
50
|
An oligomer complementary to the 5' end region of MDR1 gene decreases resistance to doxorubicin of human adenocarcinoma-resistant cells.
|
Anticancer Res
|
1992
|
0.76
|
|
51
|
N-myc oncogene amplification and catecholamine metabolism in patients with neuroblastoma.
|
Lancet
|
1987
|
0.76
|
|
52
|
Cisplatin-induced erythroid differentiation in K562 cells: modulation of transferrin receptor.
|
Boll Ist Sieroter Milan
|
1988
|
0.75
|
|
53
|
Prognostic significance of N-myc amplification in neuroblastoma.
|
Clin Chem
|
1990
|
0.75
|
|
54
|
N-myc oncogene amplification in a pediatric case of glioblastoma multiforme.
|
Childs Nerv Syst
|
1991
|
0.75
|
|
55
|
Cisplatin induces modulation of transferrin receptor during cellular differentiation in vitro.
|
Cancer Chemother Pharmacol
|
1986
|
0.75
|
|
56
|
[Detection of carriers of hemophilia A using 3 methods of statistical analysis].
|
Haematologica
|
1982
|
0.75
|
|
57
|
N-myc and MDR1 expression are mutually exclusive in NB tumors at onset.
|
Prog Clin Biol Res
|
1991
|
0.75
|
|
58
|
Methisoprinol effect on enriched B and T lymphocyte populations stimulated with phytohemagglutinin.
|
Boll Ist Sieroter Milan
|
1981
|
0.75
|
|
59
|
Does N-myc amplification correlate with other prognostic factors in advanced neuroblastoma? Preliminary results.
|
Pediatr Hematol Oncol
|
1986
|
0.75
|
|
60
|
Immunological evaluation of 15 children with non-Hodgkin lymphoma.
|
Haematol Blood Transfus
|
1977
|
0.75
|
|
61
|
Restriction fragment length polymorphism analysis reveals different allele frequency and a linkage disequilibrium at locus D1S94 in neuroblastoma patients.
|
Eur J Cancer
|
1997
|
0.75
|
|
62
|
Different regulation of mid-size neurofilament and N-myc mRNA expression during neuroblastoma cell differentiation induced by retinoic acid.
|
Cell Mol Neurobiol
|
1990
|
0.75
|
|
63
|
[Oncogenes and neoplasms in children: hemo-lymphoproliferative diseases. II].
|
Minerva Pediatr
|
1986
|
0.75
|
|
64
|
Lymphoid cell surface markers in acute lymphocytic leukaemia.
|
Scand J Haematol
|
1978
|
0.75
|
|
65
|
Methisoprinol effect on enriched B and T lymphocyte populations stimulated with phytohemagglutinin.
|
J Immunopharmacol
|
1982
|
0.75
|
|
66
|
Human serum thymic factor in antaxia-telangiectasia.
|
N Engl J Med
|
1978
|
0.75
|
|
67
|
MYCN amplification does not affect survival of neuroblastoma patients treated with autologous bone marrow transplantation.
|
Bone Marrow Transplant
|
1991
|
0.75
|
|
68
|
Haemophilia 'A' in a 46,X,i(Xq) female.
|
Br J Haematol
|
1979
|
0.75
|
|
69
|
[Antithrombin III in the 1st days of life].
|
Minerva Pediatr
|
1982
|
0.75
|
|
70
|
[Oncogenes and neoplasms in children: solid tumors. I].
|
Minerva Pediatr
|
1986
|
0.75
|
|
71
|
The specific inhibitor of protein kinase C, 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine (H7), induces morphological change and cell differentiation of human neural crest-derived cell lineages.
|
FEBS Lett
|
1990
|
0.75
|
|
72
|
[In vitro synthesis of interleukin 2 (IL-2) by T lymphocytes extracted from a lymphoepithelial thymoma. Purification and biochemical characterization].
|
Boll Ist Sieroter Milan
|
1985
|
0.75
|
|
73
|
Human serum thymic factor increases E-rosettes in acute lymphocytic leukaemia.
|
Lancet
|
1977
|
0.75
|
|
74
|
An abnormal inherited fibrinogen (fibrinogen Genova) with delayed fibrin aggregation.
|
Scand J Haematol
|
1982
|
0.75
|
|
75
|
Expression of members of the chromogranin family in primary neuroblastomas.
|
Diagn Mol Pathol
|
1992
|
0.75
|
|
76
|
[Study of the immunosuppressive effect of some anticonvulsants in children].
|
Minerva Pediatr
|
1977
|
0.75
|
|
77
|
Aspecific transfer factor in children with Hodgkin's disease.
|
Boll Ist Sieroter Milan
|
1976
|
0.75
|
|
78
|
[Amplification of the N-myc cellular oncogene in neuroblastoma. Relation to other tumor markers].
|
Boll Ist Sieroter Milan
|
1986
|
0.75
|
|
79
|
[Activation of cellular N-myc oncogene in neuroblastoma].
|
Clin Ter
|
1988
|
0.75
|
|
80
|
EBNA-negative polyclonal B cells derived from a long-term culture of unclassified acute lymphoblastic leukemia: IL-2-like activity of culture's supernatant.
|
Int J Cell Cloning
|
1986
|
0.75
|
|
81
|
Immune evaluation of 50 children with neuroblastoma at onset.
|
Med Pediatr Oncol
|
1982
|
0.75
|